Nan Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nan Huang has a total of 152 co-authors. Here are the top co-authors by number of shared publications:
- Yong Xiang Leng
Sichuan Province International Science and Technology Cooperation Base of Functional Materials, College of Medicine, Southwest Jiaotong University, Chengdu 610031, China
11 shared publications - Jialong Chen
Anhui Medical University, Key Lab. of Oral Diseases Research of Anhui Province College & Hospital of Stomatology Hefei, 230032
7 shared publications Junying Chen
Key Lab of Advanced Technology of Materials of Education Ministry, Southwest Jiaotong University, Chengdu 610031, China; School of Materials Science and Engineering, Southwest Jiaotong University, Chengdu 610031, China
7 shared publications- Manfred F. Maitz
Leibniz-Institut für Polymerforschung Dresden e.V., Dresden, Germany
7 shared publications Pengkai Qi
Key Laboratory of Advanced Technology for Materials of Education Ministry, Southwest Jiaotong University, Chengdu 610031, China and Laboratory of Biosensing and MicroMechatronics, Southwest Jiaotong University, Chengdu 610031, China
7 shared publicationsQiufen Tu
Key Laboratory of Advanced Technology for Materials of Education Ministry, Southwest Jiaotong University, Chengdu 610031, China and Laboratory of Biosensing and MicroMechatronics, Southwest Jiaotong University, Chengdu 610031, China
7 shared publications
Latest Publications
- Open Access
- 13 November 2026
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 14 (11)
Potential Role of a Rare HCCS Variant Associated With Microphthalmia With Linear Skin Defects and Phenotypic Heterogeneity
Background: Pathogenic variants in the HCCS gene have been reported to cause microphthalmia with linear skin defects (MLS). This study reports a rare HCCS variant that co‐occurs with a recurrent 2q13 microdeletion in a fetus with multiple congenital malformations, to deepen our understanding of unexplained copy number variants (CNVs). Methods: A fetus with multiple prenatal ultrasound anomalies, including flat facial profile, anophthalmia, cleft lip and palate, and widened cerebral fissures, was recruited from the Quanzhou region of China. Chromosomal microarray analysis (CMA) was performed to detect chromosomal abnormalities. Trio whole exome sequencing (trio WES) was further conducted to identify additional genetic variants within the family, and candidate variants were validated by Sanger sequencing and/or quantitative polymerase chain reaction (qPCR). Results: CMA revealed a 482.1 kb microdeletion at 2q13 (arr [GRCh37] 2q13 (110498142_110980295) × 1) encompassing the NPHP1 gene, which was inherited from the clinically unaffected father. Additionally, trio WES identified a heterozygous missense variant NM_005333.5:c.572A>T p.(Glu191Val) in the HCCS gene of the fetus, inherited from the clinically asymptomatic mother. Notably, a 1.56 Mb microdeletion spanning 16p13.11p13.12 was detected in the mother. This deletion covers the recurrent 16p13.11 BP2 to BP3 region, which includes the MYH11 gene, and is classified as a pathogenic CNV. Conclusion: To our knowledge, this is the first report of the rare HCCS variant NM_005333.5:c.572A>T p.(Glu191Val) combined with a 2q13 microdeletion in a fetus with multiple malformations. Our findings further enhance the diagnostic utility of WES in the etiological investigation of cases with unexplained CNVs.
- 13 November 2026
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 14 (11)
Open AccessPotential Role of a Rare HCCS Variant Associated With Microphthalmia With Linear Skin Defects and Phenotypic Heterogeneity
Background: Pathogenic variants in the HCCS gene have been reported to cause microphthalmia with linear skin defects (MLS). This study reports a rare HCCS variant that co‐occurs with a recurrent 2q13 microdeletion in a fetus with multiple congenital malformations, to deepen our understanding of unexplained copy number variants (CNVs). Methods: A fetus with multiple prenatal ultrasound anomalies, including flat facial profile, anophthalmia, cleft lip and palate, and widened cerebral fissures, was recruited from the Quanzhou region of China. Chromosomal microarray analysis (CMA) was performed to detect chromosomal abnormalities. Trio whole exome sequencing (trio WES) was further conducted to identify additional genetic variants within the family, and candidate variants were validated by Sanger sequencing and/or quantitative polymerase chain reaction (qPCR). Results: CMA revealed a 482.1 kb microdeletion at 2q13 (arr [GRCh37] 2q13 (110498142_110980295) × 1) encompassing the NPHP1 gene, which was inherited from the clinically unaffected father. Additionally, trio WES identified a heterozygous missense variant NM_005333.5:c.572A>T p.(Glu191Val) in the HCCS gene of the fetus, inherited from the clinically asymptomatic mother. Notably, a 1.56 Mb microdeletion spanning 16p13.11p13.12 was detected in the mother. This deletion covers the recurrent 16p13.11 BP2 to BP3 region, which includes the MYH11 gene, and is classified as a pathogenic CNV. Conclusion: To our knowledge, this is the first report of the rare HCCS variant NM_005333.5:c.572A>T p.(Glu191Val) combined with a 2q13 microdeletion in a fetus with multiple malformations. Our findings further enhance the diagnostic utility of WES in the etiological investigation of cases with unexplained CNVs.
- Open Access
Genotype-phenotype correlation analysis of patients with thalassemia in quanzhou city, southeast of China
- Open Access
- 17 February 2022
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 10, 855471
Enhanced Hemocompatibility of Silver Nanoparticles Using the Photocatalytic Properties of Titanium Dioxide
Silver nanoparticles (AgNPs) are widely used because of their excellent antimicrobial properties. However, the poor hemocompatibility limits the application of AgNPs in blood contact materials. General approaches to improve the hemocompatibility of AgNPs-containing surfaces are to construct barrier layers or co-immobilize anticoagulant biomolecules. But such modification strategies are often cumbersome to prepare and have limited applications. Therefore, this study proposes a simple UV-photo-functionalization strategy to improve the hemocompatibility of AgNPs. We loaded AgNPs onto titanium dioxide (TiO2) nanoparticles to form a composite nanoparticles (Ag@TiO2NPs). Then, UV treatment was performed to the Ag@TiO2NPs, utilizing the diffusible photo-induced anticoagulant properties of TiO2 nanoparticles to enhance the hemocompatibility of AgNPs. After being deposited onto the PU surface, the photo-functionalized Ag@TiO2NPs coating showed excellent antibacterial properties against both Gram-positive/Gram-negative bacteria. Besides, In vitro and ex-vivo experiments demonstrated that the photo-functionalized Ag@TiO2NPs coating had desirable hemocompatibility. This modification strategy can provide a new solution idea to improve the hemocompatibility of metal nanoparticles.
- 17 February 2022
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 10, 855471
Open AccessEnhanced Hemocompatibility of Silver Nanoparticles Using the Photocatalytic Properties of Titanium Dioxide
Silver nanoparticles (AgNPs) are widely used because of their excellent antimicrobial properties. However, the poor hemocompatibility limits the application of AgNPs in blood contact materials. General approaches to improve the hemocompatibility of AgNPs-containing surfaces are to construct barrier layers or co-immobilize anticoagulant biomolecules. But such modification strategies are often cumbersome to prepare and have limited applications. Therefore, this study proposes a simple UV-photo-functionalization strategy to improve the hemocompatibility of AgNPs. We loaded AgNPs onto titanium dioxide (TiO2) nanoparticles to form a composite nanoparticles (Ag@TiO2NPs). Then, UV treatment was performed to the Ag@TiO2NPs, utilizing the diffusible photo-induced anticoagulant properties of TiO2 nanoparticles to enhance the hemocompatibility of AgNPs. After being deposited onto the PU surface, the photo-functionalized Ag@TiO2NPs coating showed excellent antibacterial properties against both Gram-positive/Gram-negative bacteria. Besides, In vitro and ex-vivo experiments demonstrated that the photo-functionalized Ag@TiO2NPs coating had desirable hemocompatibility. This modification strategy can provide a new solution idea to improve the hemocompatibility of metal nanoparticles.
- Open Access
- 6 September 2020
- Published by Oxford University Press (OUP) in Regenerative Biomaterials
- Vol. 7 (5) , 491-504
Preparation of phospholipid-based polycarbonate urethanes for potential applications of blood-contacting implants
Polyurethanes are widely used in interventional devices due to the excellent physicochemical property. However, non-specific adhesion and severe inflammatory response of ordinary polyurethanes may lead to severe complications of intravenous devices. Herein, a novel phospholipid-based polycarbonate urethanes (PCUs) were developed via two-step solution polymerization by direct synthesis based on functional raw materials. Furthermore, PCUs were coated on biomedical metal sheets to construct biomimetic anti-fouling surface. The results of stress–strain curves exhibited excellent tensile properties of PCUs films. Differential scanning calorimetry results indicated that the microphase separation of such PCUs polymers could be well regulated by adjusting the formulation of chain extender, leading to different biological response. In vitro blood compatibility tests including bovine serum albumin adsorption, fibrinogen adsorption and denaturation, platelet adhesion and whole-blood experiment showed superior performance in inhibition non-specific adhesion of PCUs samples. Endothelial cells and smooth muscle cells culture tests further revealed a good anti-cell adhesion ability. Finally, animal experiments including ex vivo blood circulation and subcutaneous inflammation animal experiments indicated a strong ability in anti-thrombosis and histocompatibility. These results high light the strong anti-adhesion property of phospholipid-based PCUs films, which may be applied to the blood-contacting implants such as intravenous catheter or antithrombotic surface in the future.
- 6 September 2020
- Published by Oxford University Press (OUP) in Regenerative Biomaterials
- Vol. 7 (5) , 491-504
Open AccessPreparation of phospholipid-based polycarbonate urethanes for potential applications of blood-contacting implants
Polyurethanes are widely used in interventional devices due to the excellent physicochemical property. However, non-specific adhesion and severe inflammatory response of ordinary polyurethanes may lead to severe complications of intravenous devices. Herein, a novel phospholipid-based polycarbonate urethanes (PCUs) were developed via two-step solution polymerization by direct synthesis based on functional raw materials. Furthermore, PCUs were coated on biomedical metal sheets to construct biomimetic anti-fouling surface. The results of stress–strain curves exhibited excellent tensile properties of PCUs films. Differential scanning calorimetry results indicated that the microphase separation of such PCUs polymers could be well regulated by adjusting the formulation of chain extender, leading to different biological response. In vitro blood compatibility tests including bovine serum albumin adsorption, fibrinogen adsorption and denaturation, platelet adhesion and whole-blood experiment showed superior performance in inhibition non-specific adhesion of PCUs samples. Endothelial cells and smooth muscle cells culture tests further revealed a good anti-cell adhesion ability. Finally, animal experiments including ex vivo blood circulation and subcutaneous inflammation animal experiments indicated a strong ability in anti-thrombosis and histocompatibility. These results high light the strong anti-adhesion property of phospholipid-based PCUs films, which may be applied to the blood-contacting implants such as intravenous catheter or antithrombotic surface in the future.
- 2 September 2019
- Published by Taylor & Francis in Integrated Ferroelectrics
- Vol. 201 (1) , 231-240
Effect of original grain size on microstructure and properties of extruded Mg-2Zn-0.2Mn biomedical alloy
Magnesium is a biocompatible and biodegradable metal, which has attracted much interest in biomedical engineering. Cast magnesium alloy shows the low strength and plasticity at ambient temperature. Microstructure, mechanical properties and degradation properties of the extrusion pressed magnesium alloy have been investigated for biomedical application in detail by optical microscopes, mechanical properties testing and corrosion testing. The magnesium alloy ingots were gained by different cooling rate. Then the ingots were extrude into bar at the same processing condition. The results show that the cooling rate of cast ingot is important factors that affect the properties of Mg alloy by dynamic recrystallisation extruding. The cooling rate of cast ingot has been successfully applied to control the microstructure, mechanical and degradation properties of the Mg alloy. Optical microscopy observation has indicated that the grain size of the dynamic recrystallisation extruding has been significantly decreased from fast cooling cast magnesium ingot, which has mainly contributed to the high tensile strength and good elongation. Fasting cooling rate of cast ingot and dynamic recrystallisation extruding has provided moderate corrosion resistance, which has opened a new window for materials design, especially for biomedical.
- 2 September 2019
- Published by Taylor & Francis in Integrated Ferroelectrics
- Vol. 201 (1) , 231-240
Effect of original grain size on microstructure and properties of extruded Mg-2Zn-0.2Mn biomedical alloy
Magnesium is a biocompatible and biodegradable metal, which has attracted much interest in biomedical engineering. Cast magnesium alloy shows the low strength and plasticity at ambient temperature. Microstructure, mechanical properties and degradation properties of the extrusion pressed magnesium alloy have been investigated for biomedical application in detail by optical microscopes, mechanical properties testing and corrosion testing. The magnesium alloy ingots were gained by different cooling rate. Then the ingots were extrude into bar at the same processing condition. The results show that the cooling rate of cast ingot is important factors that affect the properties of Mg alloy by dynamic recrystallisation extruding. The cooling rate of cast ingot has been successfully applied to control the microstructure, mechanical and degradation properties of the Mg alloy. Optical microscopy observation has indicated that the grain size of the dynamic recrystallisation extruding has been significantly decreased from fast cooling cast magnesium ingot, which has mainly contributed to the high tensile strength and good elongation. Fasting cooling rate of cast ingot and dynamic recrystallisation extruding has provided moderate corrosion resistance, which has opened a new window for materials design, especially for biomedical.
- 2 October 2015
- Published by American Vacuum Society in Biointerphases
- Vol. 10 (4) , 04A303
Development of nitric oxide catalytic coatings by conjugating 3,3-disulfodipropionic acid and 3,3-diselenodipropionic acid for improving hemocompatibility
Nitric oxide (NO), discovered as an endothelium-derived relaxing factor, has been found to have multiple intracellular effects in vascular diseases including vasorelaxation regulation, endothelial regeneration, inhibition of leukocyte chemotaxis, and platelet activation. In the work described here, the authors have developed a NO-catalytic bioactive coating for improving hemocompatibility. The authors first prepared a dopamine and hexamethylendiamine (PDAM/HD) amine-rich adherent copolymer coating to introduce amine groups onto 316L stainless steel, followed by covalently conjugating 3,3-disulfodipropionic acid (S-S) and 3,3-diselenodipropionic acid (Se-Se), which mimic glutathione peroxidase-like catalytic production of NO. S-S and Se-Se were immobilized on the PDAM/HD surface via carbodiimide coupling chemistry. X-ray photoelectron spectroscopy analysis revealed clear S2p and Se3d signals, confirming the immobilization of S-S and Se-Se on the PDAM/HD surface. The NO release behavior of different samples was investigated. In detail, two species of thionitrites (RSNO), S-nitrosoglutathione (GSNO, endogenous NO donors) and S-nitrosoacetylpenicillamine (SNAP) were chosen as NO donors to investigate the NO catalytic properties of S-S and Se-Se modified PDAM/HD surfaces. Not only Se-Se@PDAM/HD but also S-S@PDAM/HD coatings showed the ability to continuously catalyze RSNO to generate NO in the presence of proper thiol reducing agent. For the Se-Se@PDAM/HD coating, the NO release amount and rate were greater than S-S@PDAM/HD in both GSNO and SNAP conditions. The results showed that organosulfide species possesses NO catalytic ability as well as organoselenium species. The authors demonstrated that both S-S@PDAM/HD and Se-Se@PDAM/HD coatings exhibited outstanding inhibition effect on platelet adhesion, aggregation and activation via the cyclic guanylate monophosphate signal pathway. Thus these results suggested that NO catalytic coatings based on organoselenium and organosulfide species immobilization can help to improve hemocompatibility. NO-catalytic strategies possess huge potential applications in blood-contacting devices.
- 2 October 2015
- Published by American Vacuum Society in Biointerphases
- Vol. 10 (4) , 04A303
Development of nitric oxide catalytic coatings by conjugating 3,3-disulfodipropionic acid and 3,3-diselenodipropionic acid for improving hemocompatibility
Nitric oxide (NO), discovered as an endothelium-derived relaxing factor, has been found to have multiple intracellular effects in vascular diseases including vasorelaxation regulation, endothelial regeneration, inhibition of leukocyte chemotaxis, and platelet activation. In the work described here, the authors have developed a NO-catalytic bioactive coating for improving hemocompatibility. The authors first prepared a dopamine and hexamethylendiamine (PDAM/HD) amine-rich adherent copolymer coating to introduce amine groups onto 316L stainless steel, followed by covalently conjugating 3,3-disulfodipropionic acid (S-S) and 3,3-diselenodipropionic acid (Se-Se), which mimic glutathione peroxidase-like catalytic production of NO. S-S and Se-Se were immobilized on the PDAM/HD surface via carbodiimide coupling chemistry. X-ray photoelectron spectroscopy analysis revealed clear S2p and Se3d signals, confirming the immobilization of S-S and Se-Se on the PDAM/HD surface. The NO release behavior of different samples was investigated. In detail, two species of thionitrites (RSNO), S-nitrosoglutathione (GSNO, endogenous NO donors) and S-nitrosoacetylpenicillamine (SNAP) were chosen as NO donors to investigate the NO catalytic properties of S-S and Se-Se modified PDAM/HD surfaces. Not only Se-Se@PDAM/HD but also S-S@PDAM/HD coatings showed the ability to continuously catalyze RSNO to generate NO in the presence of proper thiol reducing agent. For the Se-Se@PDAM/HD coating, the NO release amount and rate were greater than S-S@PDAM/HD in both GSNO and SNAP conditions. The results showed that organosulfide species possesses NO catalytic ability as well as organoselenium species. The authors demonstrated that both S-S@PDAM/HD and Se-Se@PDAM/HD coatings exhibited outstanding inhibition effect on platelet adhesion, aggregation and activation via the cyclic guanylate monophosphate signal pathway. Thus these results suggested that NO catalytic coatings based on organoselenium and organosulfide species immobilization can help to improve hemocompatibility. NO-catalytic strategies possess huge potential applications in blood-contacting devices.
- 1 September 2015
- Published by Elsevier in Biomaterials
- Vol. 63, 80-92
Nitric oxide producing coating mimicking endothelium function for multifunctional vascular stents
- 1 September 2015
- Published by Elsevier in Biomaterials
- Vol. 63, 80-92
Nitric oxide producing coating mimicking endothelium function for multifunctional vascular stents
- 1 February 2015
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 126, 70-79
Immobilization of DNA aptamers via plasma polymerized allylamine film to construct an endothelial progenitor cell-capture surface
- 1 February 2015
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 126, 70-79
Immobilization of DNA aptamers via plasma polymerized allylamine film to construct an endothelial progenitor cell-capture surface
- Open Access
- 6 January 2015
- Published by Oxford University Press (OUP) in Regenerative Biomaterials
- Vol. 2 (1) , 59-69
Absorbable magnesium-based stent: physiological factors to consider for in vitro degradation assessments
Absorbable metals have been widely tested in various in vitro settings using cells to evaluate their possible suitability as an implant material. However, there exists a gap between in vivo and in vitro test results for absorbable materials. A lot of traditional in vitro assessments for permanent materials are no longer applicable to absorbable metallic implants. A key step is to identify and test the relevant microenvironment and parameters in test systems, which should be adapted according to the specific application. New test methods are necessary to reduce the difference between in vivo and in vitro test results and provide more accurate information to better understand absorbable metallic implants. In this investigative review, we strive to summarize the latest test methods for characterizing absorbable magnesium-based stent for bioabsorption/biodegradation behavior in the mimicking vascular environments. Also, this article comprehensively discusses the direction of test standardization for absorbable stents to paint a more accurate picture of the in vivo condition around implants to determine the most important parameters and their dynamic interactions.
- 6 January 2015
- Published by Oxford University Press (OUP) in Regenerative Biomaterials
- Vol. 2 (1) , 59-69
Open AccessAbsorbable magnesium-based stent: physiological factors to consider for in vitro degradation assessments
Absorbable metals have been widely tested in various in vitro settings using cells to evaluate their possible suitability as an implant material. However, there exists a gap between in vivo and in vitro test results for absorbable materials. A lot of traditional in vitro assessments for permanent materials are no longer applicable to absorbable metallic implants. A key step is to identify and test the relevant microenvironment and parameters in test systems, which should be adapted according to the specific application. New test methods are necessary to reduce the difference between in vivo and in vitro test results and provide more accurate information to better understand absorbable metallic implants. In this investigative review, we strive to summarize the latest test methods for characterizing absorbable magnesium-based stent for bioabsorption/biodegradation behavior in the mimicking vascular environments. Also, this article comprehensively discusses the direction of test standardization for absorbable stents to paint a more accurate picture of the in vivo condition around implants to determine the most important parameters and their dynamic interactions.
- 1 December 2014
- Published by Elsevier in Acta Biomaterialia
- Vol. 10 (12) , 5213-5223
Flow-induced corrosion behavior of absorbable magnesium-based stents
- 1 December 2014
- Published by Elsevier in Acta Biomaterialia
- Vol. 10 (12) , 5213-5223
Flow-induced corrosion behavior of absorbable magnesium-based stents